TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
BDSX

Biodesix Inc

Healthcare · Diagnostics & Research

29.10$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Biodesix Inc (BDSX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 88 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BDSX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
20 25 46 55 38 49 71 88
4.4 6.1 22 31 14 13 16 17
16 18 24 24 24 36 56 72
8.2 10 11 13 13 10.0 9.6 12
26 31 35 51 61 68 80 88
34 45 46 65 75 77 90 100
-23 -27 -23 -41 -51 -41 -34 -28
2.9 3.0 7.6 4.5 8.1 9.5 8.3 7.7
-26 -31 -31 -43 -65 -52 -43 -35
0.2 0.6 5.1 1.3 15 5.3 – –
-26 -31 -31 -43 -65 -52 -43 -35
-22 -25 -21 -35 -52 -37 -29 -22

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?